Influenza Vaccine (CP-PRO-QVLP-012)

Influenza (flu) is caused by a virus (a germ) and is spread by contact with nasal (nose) and oral (mouth) secretions. Symptoms include sudden fever, headache, chills, muscle aches, and cough. The main strategy of prevention and control of flu is vaccination. The virus that causes flu usually changes a little bit each year. Therefore, the flu vaccine might change from year to year.

In this study, the vaccine is made with a new technology using tobacco plants (not the same as cigarettes are made from, but from the same family). This species of plant has been used because much is known about this family of plants.

https://clinicaltrials.gov/ct2/show/NCT03301051?term=CP-PRO-QVLP-012&rank=1

Register Today!

Let others know about this Trial!

Trial Information

Start DateSeptember, 2017
End DateApril, 2018
Trial Duration8 months
Number of Visits1 in person visit.Weekly telephone calls
Lead CRCAdam Pawluch
StatusClosed

For additional information
on this trial contact:

Phone705-566-0005